90 results on '"Brehler, Randolf"'
Search Results
2. Allergen-specific immunotherapy for mold allergies
3. Allergen immunotherapy in house dust mite-associated allergic rhinitis: efficacy of the 300 IR mite tablet
4. Avoidance measures for mite allergy—an update
5. Clinic and diagnostics of house dust mite allergy
6. Allergen characteristics, quality, major allergen content and galenics for mite allergen-specific immunotherapy preparations
7. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
8. Patients with hereditary angioedema and their treatment patterns in Germany: a Delphi consensus study
9. Allergenspezifische Immuntherapie bei Schimmelpilzallergien
10. IgE-vermittelte Nahrungsmittelallergien - eine Umfrage des Ärzteverbands Deutscher Allergologen (AeDA)
11. White paper on peanut allergy – part 1: Epidemiology, burden of disease, health economic aspects
12. Urtikaria- und Angioödemtherapie: ein Blick in die Zukunft
13. Karenzmaßnahmen bei Milbenallergie - ein Update
14. Efficacy and safety of on‐demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trial.
15. S2k guideline diagnosis, prevention, and therapy of hand eczema
16. Liebe Leserinnen und Leser,
17. S2k‐Leitlinie Diagnostik, Prävention und Therapie des Handekzems
18. Efficacy and safety of on‐demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trial
19. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
20. Zukunft der In-vivo-Allergiediagnostik in Deutschland: Welche Diagnostikallergene sind 2023 noch verfügbar?
21. Karenzmaßnahmen bei Milbenallergie - ein Update
22. Allergen-Immuntherapie bei Hausstaubmilben-assoziierter allergischer Rhinitis: Wirksamkeit der 300 IR-Milbentablette
23. S3‐Leitlinie Urtikaria. Teil 2: Therapie der Urtikaria – deutschsprachige Adaption der internationalen S3‐Leitlinie
24. Allergeneigenschaften, Qualität, Majorallergengehalt und Galenik für Milben-AIT-Präparate
25. Zukunft der In-vivo-Allergiediagnostik in Deutschland
26. Klinik und Diagnostik der Hausstaubmilbenallergie
27. S3 Guideline Urticaria. Part 2: Treatment of urticaria – German‐language adaptation of the international S3 guideline
28. Diagnosis and treatment of Hymenoptera venom allergy
29. S3 Guideline Urticaria. Part 1: Classification and diagnosis of urticaria – German‐language adaptation of the international S3 Guideline
30. Allergic asthma: An indication for allergen immunotherapy
31. S3‐Leitlinie Urtikaria. Teil 1: Klassifikation und Diagnostik der Urtikaria – deutschsprachige Adaptation der internationalen S3‐Leitlinie
32. Guideline for allergological diagnosis of drug hypersensitivity reactions
33. Rund um die Milbenallergie und ihre Auslöser
34. Allergen characteristics, quality, major allergen content and galenics for mite allergen-specific immunotherapy preparations
35. Clinic and diagnostics of house dust mite allergy
36. Management of suspected and confirmedCOVID‐19 (SARS‐CoV‐2) vaccine hypersensitivity
37. German S1 guideline: Contact dermatitis
38. S1‐Leitlinie Kontaktekzem
39. Guideline on allergen immunotherapy in IgE-mediated allergic diseases: S2K Guideline of the German Society of Allergology and Clinical Immunology (DGAKI), Society of Pediatric Allergology and Environmental Medicine (GPA), Medical Association of German Allergologists (AeDA), Austrian Society of Allergology and Immunology (ÖGAI), Swiss Society for Allergology and Immunology (SSAI), German Dermatological Society (DDG), German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), German Society of Pediatrics and Adolescent Medicine (DGKJ), Society of Pediatric Pulmonology (GPP), German Respiratory Society (DGP), German Professional Association of Otolaryngologists (BVHNO), German Association of Paediatric and Adolescent Care Specialists (BVKJ), Federal Association of Pneumologists, Sleep and Respiratory Physicians (BdP), Professional Association of German Dermatologists (BVDD)
40. Contact sensitization to essential oils: IVDK data of the years 2010–2019
41. Epidemiologie, Krankheitslast und gesundheitsökonomische Aspekte
42. Allergien auf Impfstoffe: Ein wichtiges Feld auch für HNO-Ärzte
43. German S1 guideline: Contact dermatitis
44. White Paper Erdnussallergie - Teil 1: Epidemiologie, Burden of Disease, gesundheitsökonomische Aspekte
45. Management of suspected and confirmed COVID‐19 (SARS‐CoV‐2) vaccine hypersensitivity.
46. Impact of climate change on allergic diseases in Germany.
47. S2k guideline diagnosis, prevention, and therapy of hand eczema.
48. Liebe Leserinnen und Leser.
49. S2k-Leitlinie Diagnostik, Prävention und Therapie des Handekzems: S2k guideline diagnosis, prevention and therapy of hand eczema.
50. S3-Leitlinie Urtikaria. Teil 2: Therapie der Urtikaria - deutschsprachige Adaption der internationalen S3-Leitlinie.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.